We believe that The Chemours Company (CC - Free Report) is a solid choice for investors seeking exposure in the chemical space. Its solid product offerings, strengthening end markets and expansionary efforts bode well for the future.
The stock has been upgraded to a Zacks Rank #1 (Strong Buy) on Oct 3.
Why the Upgrade?
Sentiments are positive for Chemours Company, as evident from 38.1% rally in its share price over the last six months. The stock has outperformed 12.9% gain recorded by the industry it belongs to over the same period.
Also, earnings estimates for the stock have been revised upward by a couple of analysts in the last 60 days. The Zacks Consensus Estimate for 2017 improved 6.8% from $3.40 to $3.63 while that for 2018 increased 22.5% from $4.08 to $5.
Chemours Company (The) Price and Consensus
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
We believe that The Chemours Company (CC - Free Report) is a solid choice for investors seeking exposure in the chemical space. Its solid product offerings, strengthening end markets and expansionary efforts bode well for the future.
The stock has been upgraded to a Zacks Rank #1 (Strong Buy) on Oct 3.
Why the Upgrade?
Sentiments are positive for Chemours Company, as evident from 38.1% rally in its share price over the last six months. The stock has outperformed 12.9% gain recorded by the industry it belongs to over the same period.
Also, earnings estimates for the stock have been revised upward by a couple of analysts in the last 60 days. The Zacks Consensus Estimate for 2017 improved 6.8% from $3.40 to $3.63 while that for 2018 increased 22.5% from $4.08 to $5.
Chemours Company (The) Price and Consensus
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on APD - FREE
Get the latest research report on FMC - FREE
Get the latest research report on CC - FREE